PIK3CA and acute myeloid leukemia: Upregulation of PI3K/Akt/mTOR pathway was shown in FLT3 inhibitor-resistant FLT3-ITD+ AML cells despite inhibition of FLT3 activation by FLT3 inhibitors, suggesting that the resistant cells become FLT3 independent [304,305].